BBNX logo

Beta Bionics, Inc. (BBNX) Cash From Investing

Annual CFI:

-$3.48M+$66.22M(+95.01%)
December 31, 2024

Summary

  • As of today, BBNX annual cash from investing is -$3.48 million, with the most recent change of +$66.22 million (+95.01%) on December 31, 2024.
  • During the last 3 years, BBNX annual cash from investing has fallen by -$2.71 million (-352.02%).
  • BBNX annual cash from investing is now -352.02% below its all-time high of -$769.00 thousand, reached on December 1, 2022.

Performance

1-Year Change

+95.01%

3-Year Change

-352.02%

5-Year Change

-352.02%

15-Year Change

-352.02%

BBNX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

39%
BBNX annual cash from investing is higher than 39% of companies in Healthcare sector

Range

All-Time High

-$769.00K
BBNX annual cash from investing is currently -352.02% below its historical high of -$769.00 thousand

3-Year Low

-$69.69M
BBNX annual cash from investing is currently +95.01% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BBNX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
BBNX next annual earnings announcement has not yet been scheduled

OtherBBNXcash flow metrics

Annual CFF

$55.62M
BBNX annual cash from financing is $55.62 million

Annual CFO

-$48.27M
BBNX annual cash from operations is -$48.27 million

Annual FCF

-$51.67M
BBNX annual free cash flow is -$51.67 million

Annual CAPEX

$3.40M
BBNX annual capital expenditures is $3.40 million

Quarterly CFI:

$6.17M+$185.29M(+103.45%)
June 30, 2025

Summary

  • As of today, BBNX quarterly cash from investing is $6.17 million, with the most recent change of +$185.29 million (+103.45%) on June 30, 2025.
  • Over the past year, BBNX quarterly cash from investing has increased by +$2.87 million (+87.06%).
  • BBNX quarterly cash from investing is now -59.50% below its all-time high of $15.24 million, reached on September 30, 2024.

Performance

3-Month Change

+103.45%

1-Year Change

+87.06%

3-Year Change

+7362.35%

5-Year Change

+7362.35%

BBNX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

81.12%
BBNX quarterly cash from investing is higher than 81.12% of companies in Healthcare sector

Range

All-Time High

$15.24M
BBNX quarterly cash from investing is currently -59.50% below its historical high of $15.24 million

3-Year Low

-$179.12M
BBNX quarterly cash from investing is currently +103.45% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BBNX previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 28, 2025
BBNX next earnings announcement is scheduled for Oct 28, 2025

OtherBBNXcash flow metrics

Quarterly CFF

$42.00K
BBNX quarterly cash from financing is $42.00 thousand

Quarterly CFO

-$13.59M
BBNX quarterly cash from operations is -$13.59 million

Quarterly FCF

-$15.37M
BBNX quarterly free cash flow is -$15.37 million

Quarterly CAPEX

$1.78M
BBNX quarterly capital expenditures is $1.78 million

TTM CFI:

-$187.37M+$2.87M(+1.51%)
June 30, 2025

Summary

  • As of today, BBNX TTM cash from investing is -$187.37 million, with the most recent change of +$2.87 million (+1.51%) on June 30, 2025.
  • Over the past year, BBNX TTM cash from investing has dropped by -$128.62 million (-218.93%).
  • BBNX TTM cash from investing is now -220334.12% below its all-time high of -$85.00 thousand, reached on September 30, 2023.

Performance

3-Month Change

+1.51%

1-Year Change

-218.93%

3-Year Change

-220334.12%

5-Year Change

-220334.12%

BBNX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

10.97%
BBNX TTM cash from investing is higher than 10.97% of companies in Healthcare sector

Range

All-Time High

-$85.00K
BBNX TTM cash from investing is currently >-9900.00% below its historical high of -$85.00 thousand

3-Year Low

-$190.24M
BBNX TTM cash from investing is currently +1.51% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
BBNX previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Oct 28, 2025
BBNX next earnings announcement is scheduled for Oct 28, 2025

OtherBBNXcash flow metrics

TTM CFF

$266.88M
BBNX TTM cash from financing is $266.88 million

TTM CFO

-$57.46M
BBNX TTM cash from operations is -$57.46 million

TTM FCF

-$62.05M
BBNX TTM free cash flow is -$62.05 million

TTM CAPEX

$4.59M
BBNX TTM capital expenditures is $4.59 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BBNX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+95.0%+87.1%-218.9%
3Y3 Years-352.0%+7362.4%-10000.0%
5Y5 Years-352.0%+7362.4%-10000.0%

BBNX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-352.0%+95.0%-59.5%+103.5%>-9999.0%+1.5%
5Y5-Year-352.0%+95.0%-59.5%+103.5%>-9999.0%+1.5%
All-TimeAll-Time-352.0%+95.0%-59.5%+103.5%>-9999.0%+1.5%

BBNX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$6.17M(+103.4%)
-$187.37M(+1.5%)
Mar 2025
-
-$179.12M(-503.9%)
-$190.24M(-5373.0%)
Dec 2024
-$3.48M
-$29.66M(-294.6%)
-$3.48M(+92.0%)
Sep 2024
-
$15.24M(+361.9%)
-$43.42M(+26.1%)
DateAnnualQuarterlyTTM
Jun 2024
-
$3.30M(-56.8%)
-$58.75M(+5.3%)
Mar 2024
-
$7.64M(+111.0%)
-$62.05M(+11.0%)
Dec 2023
-$69.69M(-8962.8%)
-$69.61M(>-9900.0%)
-$69.69M(>-9900.0%)
Sep 2023
-
-$85.00K
-$85.00K
Dec 2022
-$769.00K
-
-

FAQ

  • What is Beta Bionics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. annual cash from investing year-on-year change?
  • What is Beta Bionics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. quarterly cash from investing year-on-year change?
  • What is Beta Bionics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. TTM cash from investing year-on-year change?

What is Beta Bionics, Inc. annual cash from investing?

The current annual cash from investing of BBNX is -$3.48M

What is the all-time high annual cash from investing for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high annual cash from investing is -$769.00K

What is Beta Bionics, Inc. annual cash from investing year-on-year change?

Over the past year, BBNX annual cash from investing has changed by +$66.22M (+95.01%)

What is Beta Bionics, Inc. quarterly cash from investing?

The current quarterly cash from investing of BBNX is $6.17M

What is the all-time high quarterly cash from investing for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high quarterly cash from investing is $15.24M

What is Beta Bionics, Inc. quarterly cash from investing year-on-year change?

Over the past year, BBNX quarterly cash from investing has changed by +$2.87M (+87.06%)

What is Beta Bionics, Inc. TTM cash from investing?

The current TTM cash from investing of BBNX is -$187.37M

What is the all-time high TTM cash from investing for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high TTM cash from investing is -$85.00K

What is Beta Bionics, Inc. TTM cash from investing year-on-year change?

Over the past year, BBNX TTM cash from investing has changed by -$128.62M (-218.93%)
On this page